JP2007519743A5 - - Google Patents

Download PDF

Info

Publication number
JP2007519743A5
JP2007519743A5 JP2006551509A JP2006551509A JP2007519743A5 JP 2007519743 A5 JP2007519743 A5 JP 2007519743A5 JP 2006551509 A JP2006551509 A JP 2006551509A JP 2006551509 A JP2006551509 A JP 2006551509A JP 2007519743 A5 JP2007519743 A5 JP 2007519743A5
Authority
JP
Japan
Prior art keywords
composition
alkyl
aryl
substituted
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2006551509A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007519743A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/002755 external-priority patent/WO2005072408A2/en
Publication of JP2007519743A publication Critical patent/JP2007519743A/ja
Publication of JP2007519743A5 publication Critical patent/JP2007519743A5/ja
Withdrawn legal-status Critical Current

Links

JP2006551509A 2004-01-29 2005-01-31 ウイルス障害の処置 Withdrawn JP2007519743A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US54042904P 2004-01-29 2004-01-29
US56048404P 2004-04-07 2004-04-07
PCT/US2005/002755 WO2005072408A2 (en) 2004-01-29 2005-01-31 Treating a viral disorder

Publications (2)

Publication Number Publication Date
JP2007519743A JP2007519743A (ja) 2007-07-19
JP2007519743A5 true JP2007519743A5 (https=) 2008-03-06

Family

ID=34830506

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006551509A Withdrawn JP2007519743A (ja) 2004-01-29 2005-01-31 ウイルス障害の処置

Country Status (6)

Country Link
US (1) US20050256181A1 (https=)
EP (1) EP1734950A4 (https=)
JP (1) JP2007519743A (https=)
AU (1) AU2005208934A1 (https=)
CA (1) CA2553814A1 (https=)
WO (1) WO2005072408A2 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060074124A1 (en) * 2003-09-12 2006-04-06 Andrew Napper Methods of treating a disorder
MX2007003371A (es) * 2004-09-23 2007-05-07 Wyeth Corp Derivados de carbazol y ciclopentaindol para tratar infeccion con virus de hepatitis c.
US20090022694A1 (en) * 2005-10-18 2009-01-22 Distefano Peter Sirt1 inhibition
WO2008019825A1 (en) * 2006-08-14 2008-02-21 Santhera Pharmaceuticals (Schweiz) Ag Use of tricyclic indole derivatives for the treatment of muscular diseases
WO2008156656A2 (en) * 2007-06-13 2008-12-24 State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Method for making biaryl compounds, compounds made by the method, and method for their use
WO2009148571A1 (en) * 2008-06-02 2009-12-10 The Trustees Of Princeton University Inhibition of quorum sensing-mediated processes in bacteria
WO2011043827A1 (en) * 2009-10-09 2011-04-14 Nestec S.A. Methods for preventing or treating sarcopenia and muscle atrophy in animals
AR088377A1 (es) 2011-10-20 2014-05-28 Siena Biotech Spa Proceso para la preparacion de 6-cloro-2,3,4,9-tetrahidro-1h-carbazol-1-carboxamida y compuestos intermedios de esta
TW201726617A (zh) 2016-01-06 2017-08-01 奧斯佩生物製藥公司 Sirt1受體的四氫咔唑抑制劑
US20230255933A1 (en) * 2020-07-06 2023-08-17 Crescenta Biosciences Antiviral use of fabp4 modulating compounds
US12138243B2 (en) 2021-12-31 2024-11-12 Crescenta Biosciences Antiviral use of FABP4 modulating compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2301586A1 (en) * 1997-08-28 1999-03-04 William Louis Macias Method for treatment of non-rheumatoid arthritis
WO1999025340A1 (en) * 1997-11-14 1999-05-27 Eli Lilly And Company Treatment for alzheimer's disease
US20040005574A1 (en) * 2002-07-08 2004-01-08 Leonard Guarente SIR2 activity
US7351542B2 (en) * 2002-05-20 2008-04-01 The Regents Of The University Of California Methods of modulating tubulin deacetylase activity

Similar Documents

Publication Publication Date Title
JP2007529422A5 (https=)
JP2007519743A5 (https=)
JP2008513370A5 (https=)
JP2008509166A5 (https=)
AR042658A1 (es) Derivados de 1,5-diaril-pirrol-3-carboxamida y su uso como moduladores de receptores canabinoides
JP2007505148A5 (https=)
JP2007515429A5 (https=)
AR042127A1 (es) Quinolinas, isoquinolinas y quinazolin- oxialquilamidas y sus usos como fungicidas
CA2495967A1 (fr) Nouveau procede de synthese et nouvelle forme cristalline de l'agomelatine ainsi que les compositions pharmaceutiques qui la contiennent
JP2009537469A5 (https=)
HRP20140884T1 (hr) Derivati fenoksipiridinilamida i njihova primjena u lijeäśenju bolesnih stanja posredovanih inhibitorima pde4
AR065276A1 (es) Herbicidas de n-oxidos de piridina sustituidos
JP2011513305A5 (https=)
IL177537A (en) Viral polymerase inhibitors, and pharmacological compounds containing them
JP2006518728A5 (https=)
JP2004527515A5 (https=)
JP2004523582A5 (https=)
AR080531A1 (es) Derivados de triazol como insecticidas
PE20070041A1 (es) Amidas de acido pirazolcarboxilico
JP2018530582A5 (https=)
ZA200711080B (en) 1-(2-amino-3-(substituted alkyl)-3H-benzimidazoilymethyl)-3-substituted-1,3-dihydro-benzoimidazol-2-ones with activity on respiratory syncytial virus
WO2007083182A3 (en) Novel heterocycles
JP2017510645A5 (https=)
TNSN07395A1 (en) Novel phenyl-pyridinyl-piperazine derivatives, a method for the production thereof and pharmaceutical compositions containing said derivatives
US8222404B2 (en) [1,2,4]Thiadiazin-3-yl acetic acid compound and methods of making the acetic acid compound